Stock Market & Financial Investment News

News Breaks November 2, 2011 07:16 EDT AUXL theflyonthewall.com: Auxilium announces payment rates for 2012 have been released Auxilium Pharmaceuticals announced that the Center for Medicare and Medicaid Services, or CMS, released the payment rates for the 2012 Current Procedural Terminology codes last night that will be used with XIAFLEX for the treatment of adult Dupuytren's contracture patients with a palpable cord beginning January 1, 2012. The two new Category I CPT codes, issued by the American Medical Association for 2012, are 20527 for the XIAFLEX injection procedure and 26341 for the finger extension or manipulation procedure, administered 24 hours following the XIAFLEX injection, as per the label. The finger extension code payment will cover any additional patient follow-up visits up to 10 days after the extension. The CPT codes will apply to the procedures only, and leave in place the separate J code for reimbursement of the product. Medicare payment rates for the CPT codes listed below in Table 1 are a national average and will vary based on geographical adjustments. :theflyonthewall.com News For AUXL From The Last 14 Days Check below for free stories on AUXL the last two weeks. There are 11 items on the Fly with pertinent information. Sign up for a free trial to see the rest of the stories you've been missing. May 22, 2012 09:38 EDT AUXL theflyonthewall.com: Auxilium upgraded to Buy from Neutral at MKM Partners (pre-open) :theflyonthewall.com May 21, 2012 07:04 EDT AUXL theflyonthewall.com: Auxilium lowers FY12 net loss to ($10M)-($5M) from ($15M)-($5M) Subscribe for More Information :theflyonthewall.com 07:03 EDT AUXL theflyonthewall.com: Auxilium raises FY12 global Testim revenue to $225M-$235M from $215M-$225M :theflyonthewall.com 07:03 EDT AUXL theflyonthewall.com: Auxilium raises FY12 revenue to $293M-$315M from $283M-$305M Subscribe for More Information :theflyonthewall.com 07:02 EDT AUXL theflyonthewall.com: Auxilium, GlaxoSmithKline enter co-promotion agreement for Testim Auxilium (AUXL) and GlaxoSmithKline LLC, the U.S. subsidiary of GlaxoSmithKline (GSK), announced that they have entered into an agreement for the co-promotion of Testim 1%, which is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of testosterone. :theflyonthewall.com May 17, 2012 07:01 EDT AUXL theflyonthewall.com: Auxilium announces issuance of composition of matter patent covering Testim Subscribe for More Information :theflyonthewall.com May 14, 2012 08:00 EDT AUXL theflyonthewall.com: Auxilium shares undervalued, says Cowen at Cowen Subscribe for More Information :theflyonthewall.com May 11, 2012 13:11 EDT AUXL theflyonthewall.com: Auxilium management to meet with RBC Capital Subscribe for More Information :theflyonthewall.com 07:50 EDT AUXL theflyonthewall.com: Auxilium risk/reward positive into data, says RBC Capital Subscribe for More Information :theflyonthewall.com May 10, 2012 07:01 EDT AUXL theflyonthewall.com: Auxilium reports Q1 EPS (4c), consensus (12c) Subscribe for More Information :theflyonthewall.com May 9, 2012 07:04 EDT AUXL theflyonthewall.com: Auxilium announces Xiaflex Phase IIb study to be published Subscribe for More Information :theflyonthewall.com